[Huntington's disease: a bimolecular vision].

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Context:

• Huntington's disease is a genetic, autosomal dominant, progressive neurodegenerative disorder.
• It is characterized by mutations in the huntingtin gene, leading to unknown protein function.
• Clinical hallmarks include chorea and behavioral disturbances, with diagnosis confirmed by genetic blood tests.

Purpose:

• To explore the pathophysiology of Huntington's disease.
• To understand the mechanisms of neurodegeneration in the striatum.
• To identify potential therapeutic targets and alternative treatments.

Summary:

• Neurodegeneration in Huntington's disease involves apoptosis, primarily affecting the striatum.
• Key factors include oxidative stress from glutamate and iron, mitochondrial dysfunction, and reduced cerebral perfusion.
• Current treatments manage symptoms like chorea and depression, with neurotransplantation as an experimental alternative.

Impact:

• Advances in understanding Huntington's disease pathophysiology offer hope for improved therapeutic strategies.
• New knowledge may lead to more effective treatments beyond current symptom management.
• Ongoing research into mechanisms like oxidative stress and mitochondrial dysfunction could reveal novel therapeutic targets.